Period of time： 2014年4期
Publisher： Informa Healthcare
Founded in： 1996
Total resources： 42
ISSN： 1472-8214
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Emerging Drugs,volume 16,issue 4
Menu
Emerging adenosine receptor agonists – an update
By Gao Zhan-Guo,Jacobson Kenneth A in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.
Access to resources
Recommend
Emerging pharmacotherapy of tinnitus
By Langguth Berthold,Elgoyhen Ana Belén in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging GLP-1 receptor agonists
By Lund Asger,Knop Filip K,Vilsbøll Tina in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging drugs which target the renin–angiotensin–aldosterone system
By Steckelings Ulrike Muscha,Paulis Ludovit,Unger Thomas,Bader Michael in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging drugs for panic disorder
By Perna Giampaolo,Guerriero Giuseppe,Caldirola Daniela in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging drugs in metastatic breast cancer: an update
By Arslan Cagatay,Altundag Kadri,Dizdar Omer in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging drugs for diabetic retinopathy
By Pipis Antonios,Scholl Stefan,Augustin Albert J in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging drugs for the treatment of transplant rejection
By Kihm Lars P,Zeier Martin,Morath Christian in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging oral drugs for relapsing–remitting multiple sclerosis
By Gasperini Claudio,Ruggieri Serena in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.Emerging pipeline drugs for hepatitis B infection
By Cox Natravis,Tillmann Hans in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 4 , Vol. 16, Iss. 4, 2011-12 , pp.
Previous
Next